Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bias in Epidemiological Studies

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Measuring and Modeling Air Pollution and Noise Exposure Near Unconventional Oil and Gas Development in Colorado.

Research report (Health Effects Institute)·2026

Same author

Continuum of care and survival in patients with metastatic colorectal cancer: results of the real-world prospective, longitudinal cohort PROMETCO study.

ESMO gastrointestinal oncology·2026

Same author

Long-term trajectories of hepatic and metabolic biomarkers after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral therapy-experienced people with HIV with and without hepatic coinfection: Data from the ICONA cohort.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2025

Same author

Vaccination coverage against three viral sexually transmitted diseases, among 18-to-30-year-olds seen between May 2023 and May 2024 in the Martinique University Hospital CeGIDD.

Infectious diseases now·2025

Same author

The effects of the COVID-19 pandemic on people living with HIV.

HIV medicine·2025

Same author

Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians' and nurses' points of view.

The Journal of antimicrobial chemotherapy·2024

Same journal

Invaders taking over-Mollusc faunal change in volcanic barrier lakes of the Albertine Rift biodiversity hotspot.

PloS one·2026

Same journal

AI-driven molecular diversification and ligand-based optimization of macitentan derivatives targeting VEGFR1 and endothelin signaling pathways.

PloS one·2026

Same journal

Performance patterns and records in the world aquatics masters championships: Where do the most frequently represented nations among the top-ten masters swimmers come from?

PloS one·2026

Same journal

Modeling diurnal Temperature-Rainfall relationships under multicollinearity using PLS-SEM: A case study of Ghana.

PloS one·2026

Same journal

Organizational culture, social capital, and emergency capacity in primary healthcare institutions: A cross-sectional structural equation modeling study comparing ordinary and older communities.

PloS one·2026

Same journal

Impact of kidney function on the metabolome in the general population.

PloS one·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 30, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study.

D Raben¹, A Mocroft², M Rayment³

¹CHIP, Rigshospitalet, Copenhagen, Denmark.

|November 13, 2015

Summary

This summary is machine-generated.

European HIV testing rates for indicator conditions (ICs) varied significantly by region, with Northern Europe showing the lowest rates. Despite high HIV prevalence in some ICs, many potential diagnoses were missed due to suboptimal testing adherence.

More Related Videos

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Published on: March 13, 2015

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

Related Experiment Videos

Last Updated: Mar 30, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Published on: March 13, 2015

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

Area of Science:

Public Health
Infectious Diseases
Epidemiology

Background:

European guidelines advocate routine HIV testing for patients with specific indicator conditions (ICs) associated with HIV.
Adherence to these HIV testing guidelines across Europe is not well-documented.

Purpose of the Study:

To audit HIV testing practices in patients presenting with indicator conditions across various European regions.
To estimate the number of potentially missed HIV diagnoses due to low testing rates.

Main Methods:

Retrospective audit of 7037 patient case notes from 23 centers across Europe, focusing on tuberculosis, lymphoma, cancers, hepatitis B/C, and oesophageal candidiasis.
Analysis of HIV test rates, uptake, and new HIV diagnosis rates.
Estimation of missed HIV diagnoses based on observed testing and positivity rates.

Main Results:

Median HIV testing rate was 72%, with significant regional variation (Northern Europe 44% vs. Eastern Europe 99%).
HIV uptake was nearly 100% where tests were offered.
A median HIV-positive rate of 0.9% was observed, with 60.4% of audits showing >0.1% positivity.
An estimated 105 HIV diagnoses may have been missed across the audited indicator conditions.

Conclusions:

HIV testing rates for established indicator conditions remain suboptimal across Europe.
Low testing rates represent missed opportunities for early HIV diagnosis and treatment.
Standardized auditing is crucial to monitor and improve adherence to HIV testing guidelines for indicator conditions.